Renowned Speakers
Sayon Roy
Boston University, USA
Mark Woodward
University of Oxford, USA
Terez Shea-Donohue
University of Maryland, USA
Stanley S. Schwartz
University of Pennsylvania, USA
Dennis C. Bruemmer
University of Pittsburg USA
Rukia Isabel Yosuf
University of Toledo College of Medicine and Life Sciences, Toledo OH, USA
Robert J. Tanenberg
East Carolina University, USA
Gerald C. Hsu
eclaire MD Foundation, USA
Recommended Global Diabetes & Endocrinology Webinars & Conferences
Asia Pacific & Middle East
Canada
Global Diabetes 2024
About Conference
The 22nd Global Conference on Diabetes, Endocrinology, and Primary Healthcare is set to take place on May 30-31, 2024, in Amsterdam, Netherlands. The conference theme for this year is "Approach towards a Diabetes free World!".
Diabetes is a growing concern worldwide, with over 400 million people suffering from the condition. This conference aims to bring together leading experts, researchers, and healthcare professionals to discuss the latest advancements in diabetes and endocrinology, primary healthcare, and their efforts towards a diabetes-free world.
The conference will feature keynote speeches, panel discussions, and workshops that will focus on the latest innovations in diabetes prevention, management, and treatment. Participants will have the opportunity to learn about the latest research findings and best practices in diabetes care from some of the world's leading experts.
In addition to learning from the experts, the conference will also provide participants with the opportunity to network with other healthcare professionals from around the world. This will provide them with a unique opportunity to share their knowledge and experience, learn about new developments in the field, and collaborate on future research projects.
The 22nd Global Conference on Diabetes, Endocrinology, and Primary Healthcare promises to be an informative and engaging event that will highlight the progress made in the field of diabetes care and the efforts towards a diabetes-free world. The conference is a must-attend event for anyone involved in diabetes care and research, and we look forward to welcoming participants from around the world to Amsterdam in 2024.
Sessions & Tracks
Session on Diabetes Management Strategies: Updates and Innovations
Diabetes management strategies have evolved over the years to include new innovations and updates in technology and treatment options. Some of the key updates in diabetes management include the use of continuous glucose monitoring (CGM) systems, insulin pumps, and smart insulin pens. These technologies allow for more precise management of blood glucose levels, which can lead to improved health outcomes for people with diabetes. Additionally, newer medications like SGLT2 inhibitors and GLP-1 receptor agonists have been shown to have significant benefits in reducing cardiovascular risk and improving glycemic control. Personalized nutrition plans, regular physical activity, and regular monitoring and communication with healthcare providers are also important components of diabetes management.
Session on Endocrinology and Hormonal Disorders: Diagnosis and Treatment
Endocrinology is the study of the endocrine system, which includes the glands and hormones that regulate bodily functions. Hormonal disorders can arise when there is an imbalance or dysfunction in this system, leading to a range of symptoms and health complications. Diagnosis of hormonal disorders typically involves blood tests, imaging, and physical exams. Treatment options may include hormone replacement therapy, medications, surgery, or lifestyle changes. Common hormonal disorders include thyroid disorders, diabetes, adrenal disorders, and reproductive disorders. Effective management of hormonal disorders requires a thorough understanding of the underlying condition and personalized treatment plans tailored to the individual patient's needs and medical history. Regular monitoring and follow-up with healthcare providers are also important for successful management of hormonal disorders.
Session on Primary Healthcare for Chronic Diseases: Best Practices
Primary healthcare plays a crucial role in the management of chronic diseases, such as diabetes, hypertension, and cardiovascular disease. Best practices in primary healthcare for chronic diseases include regular screening and monitoring, early diagnosis, and the development of personalized treatment plans. Effective communication between patients and healthcare providers is also important, as it allows for better understanding and adherence to treatment plans. Additionally, lifestyle modifications such as diet and exercise, stress reduction, and smoking cessation are important components of chronic disease management. Patient education and support can also improve health outcomes by empowering individuals to take an active role in their own care. Ultimately, successful management of chronic diseases requires a multidisciplinary approach, with healthcare providers, patients, and caregivers working together to achieve optimal health outcomes.
Session on Advances in Insulin Delivery Systems: Implications for Diabetes Management
Recent advances in insulin delivery systems have significantly improved diabetes management for individuals with type 1 and type 2 diabetes. Insulin pumps, continuous glucose monitoring systems, and smart insulin pens offer precise insulin dosing and real-time monitoring of blood glucose levels, reducing the risk of hypoglycemia and hyperglycemia. Smart insulin pens also offer the convenience of tracking insulin doses and blood glucose levels through mobile applications. These technologies offer more flexibility in diabetes management and can improve quality of life for individuals with diabetes. However, regular monitoring and communication with healthcare providers is still important to ensure effective use and management of these technologies.
Session on Thyroid Disorders: Current Trends and Treatment Options
Thyroid disorders are a common endocrine condition affecting millions of people worldwide. Current trends in thyroid disorder management focus on personalized treatment plans based on patient characteristics and disease severity. Diagnosis often involves blood tests and imaging studies, followed by appropriate management strategies, including medication, surgery, and radioactive iodine therapy. Recent advances in thyroid disorder management include the use of targeted therapy and immunotherapy for thyroid cancer. Additionally, thyroid hormone replacement therapy has been shown to improve outcomes for patients with hypothyroidism. Regular monitoring and communication with healthcare providers is essential for successful management of thyroid disorders, as adjustments to treatment plans may be necessary over time.
Session on Obesity and Metabolic Syndrome: Prevention and Treatment
Obesity and metabolic syndrome are major public health concerns that are associated with a range of serious health conditions, including diabetes, cardiovascular disease, and certain cancers. Prevention and treatment strategies for obesity and metabolic syndrome involve lifestyle modifications, such as a healthy diet, regular physical activity, and stress reduction. Additionally, medication and surgery may be appropriate for some individuals. In recent years, personalized medicine and precision health approaches have emerged as potential avenues for the prevention and treatment of obesity and metabolic syndrome. These approaches aim to tailor interventions to an individual's unique genetic, environmental, and lifestyle factors, and may lead to more effective and targeted interventions for these complex conditions.
Session on Role of Nutrition and Lifestyle Modification in Diabetes Prevention and Management
Nutrition and lifestyle modifications are key components of diabetes prevention and management. A healthy diet, rich in fruits, vegetables, whole grains, lean proteins, and healthy fats, can help individuals maintain healthy blood sugar levels, reduce the risk of developing type 2 diabetes, and improve overall health outcomes. Regular physical activity, stress reduction, and smoking cessation are also important lifestyle modifications that can improve diabetes management and prevent complications. Additionally, personalized nutrition plans that consider individual preferences and cultural traditions can improve adherence and long-term success in diabetes management. Successful diabetes prevention and management requires a multidisciplinary approach, with healthcare providers, registered dietitians, and other allied health professionals working together to provide comprehensive care.
Session on Pediatric Endocrinology: Clinical Challenges and Best Practices
Pediatric endocrinology is a specialized field of medicine that focuses on the diagnosis and treatment of hormonal disorders in children and adolescents. Clinical challenges in pediatric endocrinology include accurate diagnosis, appropriate treatment plans, and ongoing management of conditions such as type 1 diabetes, growth disorders, and disorders of puberty. Best practices in pediatric endocrinology involve a multidisciplinary approach, with healthcare providers working collaboratively with families and caregivers to develop personalized treatment plans. Regular monitoring and communication with healthcare providers are also important for successful management of pediatric endocrine disorders. Additionally, support services such as patient education, counseling, and peer support can improve health outcomes and quality of life for children and families living with these conditions.
Session on Cardiovascular Disease in Diabetes: Risk Assessment and Management
Cardiovascular disease (CVD) is a major complication of diabetes and a leading cause of morbidity and mortality worldwide. Risk assessment and management of CVD in individuals with diabetes involves regular monitoring of blood pressure, cholesterol levels, and blood sugar control, as well as lifestyle modifications such as a healthy diet, regular physical activity, and smoking cessation. Additionally, medication, such as statins and blood pressure-lowering agents, may be necessary for some individuals. Recent advances in personalized medicine and precision health approaches have led to improved risk prediction and targeted interventions for CVD in individuals with diabetes. Regular communication and collaboration between healthcare providers and individuals with diabetes are crucial for effective management and prevention of CVD.
Session on New Technologies in Diabetes Monitoring and Treatment
New technologies are revolutionizing diabetes monitoring and treatment, providing individuals with more accurate and personalized care. Continuous glucose monitoring (CGM) systems offer real-time tracking of blood glucose levels, reducing the risk of hypoglycemia and hyperglycemia. Smart insulin pens and connected devices provide easy tracking of insulin doses and blood glucose levels through mobile applications, improving medication adherence and disease management. Additionally, closed-loop insulin delivery systems, also known as artificial pancreas systems, offer automated insulin dosing based on CGM readings, reducing the burden of diabetes management for individuals. These new technologies provide individuals with more control over their diabetes management and can lead to improved health outcomes. Regular monitoring and communication with healthcare providers remain important for effective use of these new technologies.
Session on Pharmacotherapy for Type 2 Diabetes: Current and Future Trends
Pharmacotherapy plays a critical role in the management of type 2 diabetes, and new treatment options are continually emerging. Current trends in pharmacotherapy for type 2 diabetes focus on individualized treatment plans based on patient characteristics, such as age, comorbidities, and glycemic control. These treatment options include metformin, sulfonylureas, DPP-4 inhibitors, GLP-1 receptor agonists, and SGLT-2 inhibitors, among others. Additionally, newer drug classes, such as dual SGLT-1 and SGLT-2 inhibitors and GPR119 agonists, show promise for the future of type 2 diabetes pharmacotherapy. Regular monitoring and communication with healthcare providers are crucial for the effective use of these medications, and ongoing research continues to improve our understanding of optimal treatment approaches for type 2 diabetes.
Session on Diabetes and Mental Health: Implications for Patient Care
Diabetes and mental health are closely interconnected, with diabetes increasing the risk of mental health conditions such as depression and anxiety, and poor mental health exacerbating diabetes management challenges. The implications of this link for patient care include the need for a multidisciplinary approach to care, with healthcare providers addressing both physical and mental health concerns. This may involve screening for mental health conditions, providing education and support for diabetes self-management, and referring patients to mental health professionals as needed. Additionally, lifestyle modifications, such as regular physical activity and stress reduction, can improve both physical and mental health outcomes. Addressing the mental health implications of diabetes is crucial for providing comprehensive care and improving health outcomes.
Session on Diabetic Foot Ulcers: Prevention and Management Strategies
Diabetic foot ulcers are a common complication of diabetes, with up to 25% of individuals with diabetes developing a foot ulcer during their lifetime. Prevention and management strategies for diabetic foot ulcers include regular foot examinations, proper foot hygiene, and appropriate footwear. Individuals with diabetes should also be educated on proper wound care and seek medical attention for any foot injuries or infections. Multidisciplinary care teams, including podiatrists, wound care specialists, and endocrinologists, can provide comprehensive care for individuals with diabetic foot ulcers. In severe cases, surgical intervention may be necessary. Early intervention and ongoing management are crucial for preventing complications and improving outcomes for individuals with diabetic foot ulcers.
Session on Gestational Diabetes: Diagnosis and Management
Gestational diabetes is a type of diabetes that develops during pregnancy and affects approximately 10% of pregnancies worldwide. Diagnosis involves glucose screening at 24-28 weeks of gestation, with further testing if the initial screening is positive. Management of gestational diabetes involves lifestyle modifications such as healthy eating and regular physical activity, as well as blood glucose monitoring and medication as needed. Ongoing monitoring and communication with healthcare providers are crucial for effective management of gestational diabetes and preventing complications such as macrosomia and neonatal hypoglycemia. Additionally, women with gestational diabetes should be monitored for the development of type 2 diabetes postpartum.
Session on Aging and Diabetes: Challenges and Management Strategies
Aging and diabetes pose unique challenges for individuals and healthcare providers. As individuals age, their risk of developing type 2 diabetes increases, and management of diabetes becomes more complex due to age-related changes in metabolism and the presence of comorbidities. Management strategies for older adults with diabetes should focus on individualized treatment plans that consider comorbidities, cognitive function, and functional status. Additionally, lifestyle modifications such as regular physical activity and healthy eating can improve glycemic control and reduce the risk of diabetes complications. Ongoing monitoring and communication with healthcare providers are crucial for effective management of diabetes in older adults and improving health outcomes.
Session on Stem Cell Therapy for Diabetes: Current Developments and Future Prospects
Stem cell therapy has emerged as a potential treatment for diabetes, with the ability to replace damaged or destroyed insulin-producing cells in the pancreas. Current developments in stem cell therapy for diabetes include the use of embryonic stem cells, induced pluripotent stem cells, and adult stem cells. While early studies have shown promise, challenges remain in ensuring the safety and efficacy of stem cell therapy for diabetes. Future prospects for stem cell therapy include the development of personalized treatment approaches and the use of gene editing technologies to improve the function and survival of transplanted cells. Continued research and clinical trials are needed to fully realize the potential of stem cell therapy for diabetes.
Session on Telemedicine and Diabetes Care: Opportunities and Challenges
Telemedicine has emerged as a valuable tool for diabetes care, offering opportunities to improve access to care, patient engagement, and clinical outcomes. Telemedicine can facilitate remote monitoring of blood glucose levels, medication adherence, and lifestyle behaviors, as well as provide virtual consultations with healthcare providers. However, challenges remain in ensuring equitable access to telemedicine services, addressing privacy and security concerns, and ensuring the accuracy and reliability of remote monitoring devices. Additionally, telemedicine should be integrated into a comprehensive diabetes care plan and not be seen as a substitute for in-person care when necessary. Addressing these challenges will be crucial for realizing the full potential of telemedicine in diabetes care.
Session on Diabetic Neuropathy: Diagnosis and Management Strategies
Diabetic neuropathy is a common complication of diabetes that can cause nerve damage and lead to symptoms such as pain, numbness, and tingling in the hands and feet. Diagnosis involves a comprehensive evaluation of symptoms and physical examination, as well as tests such as nerve conduction studies and electromyography. Management strategies for diabetic neuropathy include glycemic control, pain management, and lifestyle modifications such as regular physical activity and smoking cessation. Additionally, medications such as antidepressants, anticonvulsants, and opioids may be used for pain management. Early detection and effective management of diabetic neuropathy are crucial for preventing further nerve damage and improving quality of life for individuals with diabetes.
Session on Precision Medicine in Diabetes: Current Status and Future Directions
Precision medicine, which uses genetic and other data to personalize medical care, has the potential to revolutionize diabetes care. Current efforts in precision medicine for diabetes include the use of genetic testing and biomarkers to predict diabetes risk, develop individualized treatment plans, and identify individuals who are most likely to benefit from specific therapies. Future directions in precision medicine for diabetes include the development of new technologies for monitoring blood glucose levels and identifying biomarkers of disease progression, as well as the use of artificial intelligence and machine learning algorithms to analyze complex data sets. Continued research and collaboration between healthcare providers and researchers will be crucial for advancing precision medicine in diabetes care.
Session on Diabetes Education and Self-Management: Empowering Patients for Better Outcomes
Diabetes education and self-management are crucial for empowering individuals with diabetes to take an active role in their care and improve their health outcomes. Diabetes education programs can provide information on blood glucose monitoring, medication management, healthy eating habits, and physical activity, as well as offer support for emotional well-being. Self-management techniques such as goal setting, problem solving, and stress management can help individuals with diabetes to successfully manage their condition and prevent complications. Additionally, peer support groups and community resources can provide further support and motivation for individuals with diabetes. By emphasizing education and self-management, healthcare providers can empower patients to take control of their health and achieve better outcomes.
Market Analysis
The Diabetes, Endocrinology, and Primary Healthcare market is a rapidly growing sector of the healthcare industry. With an increasing number of individuals being diagnosed with diabetes and other endocrine disorders, the demand for advanced treatment options and healthcare services continues to rise.
The market is characterized by the presence of a large number of players, including pharmaceutical companies, medical device manufacturers, and healthcare service providers. These players are constantly innovating and introducing new products and services to meet the growing demand for diabetes and endocrinology care.
The market is also influenced by various factors such as government policies, technological advancements, and changing demographics. In addition, the increasing awareness about the importance of early diagnosis and treatment of diabetes and endocrine disorders is driving the growth of the market.
The Asia-Pacific region is expected to be the fastest-growing market due to the increasing prevalence of diabetes and endocrine disorders in the region. North America and Europe are also expected to hold a significant share of the market.
Overall, the Diabetes, Endocrinology, and Primary Healthcare market is expected to continue to grow at a steady pace in the coming years, providing ample opportunities for players in the market to innovate and introduce new products and services.
To Collaborate Scientific Professionals around the World
Conference Date May 30-31, 2024
For Sponsors & Exhibitors
Speaker Opportunity
Useful Links
Past Conference Report
Supported By
All accepted abstracts will be published in respective Conference Series International Journals.
Abstracts will be provided with Digital Object Identifier by